Handelsavisen
prelaunch
Companies Healthcare A.BK
A
A.BK SET (Bangkok) Advanced Medical Equipment & Technology

Areeya Property PCL

$4,64
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
-2,3 %
ROE
-2,5 %
Net margin
-19,2 %
Debt / equity
3,23
Beta
52w range
Volume
Day range
Prev close
$133,39
Open
Next earnings
2026-08-28
Ex-dividend
TR 1Y
About

Areeya Property PCL is a real estate company engaged in property development, rental, and operations, generating revenue primarily through property sales and leasing activities.

Business. Areeya Property PCL (A.BK) is a real estate company engaged in rental, development, and operations activities. The firm is headquartered in Thailand and is primarily listed on the Stock Exchange of Thailand (SET). Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

Classification99 %
SectorHealth Care
Industry groupAdvanced Medical Equipment & Technology
Generated · model-assisted
Sell-side consensus
BUY23 analysts
18 buy5 hold0 sell
Avg 12m price target160,49

Analyst recommendations

23 analysts · consensus Buy
Buy18
Hold5
Sell0
12-month price target
160,49
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-08-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
23 analysts · indicative
Ownership
not yet wired
Profitability
-2,5 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning A.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to A.BK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-08-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR
    • Congressional trades
    • CongressLisa McClain — Agilent Technologies, Inc. Common2025-07-16 · Republican · MI · Sale · $1,001 - $15,000
    • CongressLisa McClain — Agilent Technologies, Inc. Common2025-06-17 · Republican · MI · Purchase · $1,001 - $15,000
    • CongressJulie Johnson — Agilent Technologies, Inc. Common2025-04-01 · Democrat · TX · Sale · $1,001 - $15,000
    • CongressJulie Johnson — Agilent Technologies, Inc. Common2025-03-03 · Democrat · TX · Sale · $1,001 - $15,000

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Areeya Property PCL (A.BK) is a real estate company engaged in rental, development, and operations activities. The firm is headquartered in Thailand and is primarily listed on the Stock Exchange of Thailand (SET). Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

    Classification99 %
    SectorHealth Care
    Industry groupAdvanced Medical Equipment & Technology
    AI synthesis
    GENERATED

    Areeya Property PCL has a liquidity risk score of medium, with a debt-to-equity ratio of 3.23, indicating a high reliance on debt financing. The company's cash and equivalents amount to 28.31 million THB, which is significantly lower than its long-term debt of 9.08 billion THB, resulting in a negative net cash position. The current ratio of 2.4 suggests the company has sufficient short-term assets to cover its short-term liabilities, but the high leverage remains a concern.

    The company's profitability is weak, with a return on equity of -2.52% and a return on assets of -0.54%, both significantly below the industry median for real estate firms. The operating income is negative at -8.64 million THB, and the net income is -70.88 million THB, indicating a loss-making position. These metrics suggest the company is underperforming relative to its peers in terms of capital efficiency and operational profitability.

    Areeya Property PCL's revenue is concentrated in a single business segment, with no disclosed geographic diversification. The company's financial snapshot does not provide segment-specific revenue breakdowns, but the lack of diversification increases exposure to regional economic downturns or regulatory changes. The absence of geographic or product diversification is a structural risk for the company.

    The company's growth trajectory is uncertain, with no disclosed revenue growth in the most recent financial period. The operating cash flow is positive at 75.77 million THB, but the free cash flow is negative at -63.61 million THB, indicating that capital expenditures and debt servicing are outpacing cash generation. The capital expenditure of -318,000 THB is minimal, suggesting limited investment in new projects or asset expansion.

    The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's negative net cash position is a key flag, but the absence of a significant difference between basic and diluted shares (980 million each) suggests no imminent dilution pressure. The risk assessment does not identify any material dilution sources in the near term, but the high leverage remains a structural concern.

    Recent filings and transcripts do not provide additional insights into the company's strategic direction or operational performance. The most recent financial data indicates a loss-making position with weak returns, but no material events or disclosures have been identified that would suggest a near-term turnaround.

    Key takeaways
    • Areeya Property PCL is highly leveraged, with a debt-to-equity ratio of 3.23, indicating significant financial risk.
    • The company is currently unprofitable, with a negative return on equity of -2.52% and a negative net income of -70.88 million THB.
    • The company's liquidity position is weak, with a negative net cash position and a free cash flow of -63.61 million THB.
    • Areeya Property PCL lacks geographic and segment diversification, increasing its exposure to regional economic and regulatory risks.
    • The company's growth trajectory is uncertain, with no disclosed revenue growth and minimal capital expenditures.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 3

    Analysts project a 3,358.8% upside to a mean price target of 160.49 THB, signaling strong institutional confidence.

    The company maintains a low leverage band with a debt-to-equity ratio of 0.45 and interest coverage of 13.2.

    Dilution risk is assessed as low, suggesting limited immediate threat to existing shareholder equity value.

    BEAR CASE · 3

    The company faces high credit risk and medium liquidity risk, indicating significant financial stability concerns.

    Operating and net margins rank in the bottom quartile of the real estate cohort, showing poor profitability.

    Return on equity is negative 2.52%, placing the company in the bottom quartile compared to peers.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2009-08-14
    Q2 2009 · Quarter highlights

    Revenue THB 369.6M; Operating income -THB 8.6M.

    RevenueTHB 369.6M
    Operating income-THB 8.6M
    Net income-THB 70.9M
    Free cash flow-THB 63.6M
    EPS
    Operating cash flowTHB 75.8M
    Financials
    Income statement
    RevenueTHB 369.6M
    Gross profitTHB 126.8M
    Operating income-THB 8.6M
    Net income-THB 70.9M
    Margins
    Gross margin34.3%
    Operating margin-2.3%
    Net margin-19.2%
    FCF margin-17.2%
    Balance sheet
    Total assetsTHB 13.19B
    Total liabilitiesTHB 10.37B
    Total equityTHB 2.81B
    Cash & equivalentsTHB 28.3M
    Long-term debtTHB 9.08B
    Cash flow
    Operating cash flowTHB 75.8M
    CapEx-THB 318.0k
    Free cash flow-THB 63.6M
    SBC
    P&L flow · revenue → net income
    Revenue THB 369.6MOperating costs THB 378.2MTax THB 62.2MNet income THB 70.9M
    Highlights
    • Revenue THB 369.6M
    • Operating income -THB 8.6M
    • Net margin -19.2%

    Valuation FY

    Market price
    $4,64
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $2.81B
    Net cash
    -$9.05B
    Current ratio
    2.4
    Debt / equity
    3.2
    ROA
    -0.5%
    ROE
    -2.5%
    Cash conversion
    -107.0%
    CapEx / revenue
    -0.1%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Gas Chromatography & Mass Spectrometry
    disclosed · segment_methodology
    Lab Services, Consumables & Automation
    disclosed · segment_methodology
    Liquid Chromatography & Mass Spectrometry
    disclosed · segment_methodology

    Market share

    INDUSTRYSEGMENTCOMPANYHealthcareIndustryAdvanced Medical Equipment & Technology170,9B node revenueTMO 26,1%DHR 14,4%GEHC 12,1%PHG 11,9%BSX 11,7%ISRG 5,9%A 4,1%EW 3,5%Other 10,4%
    Source: company disclosures · own-taxonomy revenue-covered set · attribution: collision-suspect (indicative)A 4,1% · rank #7 of 46

    Business relationships

    Business relationships10 disclosed relationships · 1 type · extracted from filings & disclosures
    Subsidiaries10
    EX21:05b635150bc3EX21:05b635150bc3Subsidiarie97%
    EX21:2832329a2a5aEX21:2832329a2a5aSubsidiarie97%
    EX21:2d330adc7459EX21:2d330adc7459Subsidiarie97%
    EX21:3f5d1c3fa3b3EX21:3f5d1c3fa3b3Subsidiarie97%
    EX21:518e81e78a35EX21:518e81e78a35Subsidiarie97%
    EX21:62c588a53e78EX21:62c588a53e78Subsidiarie97%
    EX21:ac2f3c70f055EX21:ac2f3c70f055Subsidiarie97%
    EX21:b6384db27721EX21:b6384db27721Subsidiarie97%
    EX21:edd402aa6e15EX21:edd402aa6e15Subsidiarie97%
    EX21:f733c69e2776EX21:f733c69e2776Subsidiarie97%

    Supply chain

    — missing data

    Peer comparison

    Peer comparison7 peers · vs A · multiples and returns
    TM
    TMO
    Thermo Fisher Scientific Inc
    $574,03
    214,1B USD
    P/E
    29,4x
    +0,4 vs self
    Div yield
    0,3 %
    -0,5 vs self
    ROE
    12,9 %
    -6,4 vs self
    DH
    DHR
    Danaher Corp
    $197,50
    140,1B USD
    P/E
    38,2x
    +9,2 vs self
    Div yield
    vs self
    ROE
    6,9 %
    -12,5 vs self
    GE
    GEHC
    GE HEALTHCARE TECHNOLOGIES INC.
    $69,72
    31,9B USD
    P/E
    13,6x
    -15,4 vs self
    Div yield
    0,2 %
    -0,5 vs self
    ROE
    19,5 %
    +0,2 vs self
    PH
    PHG
    PHG
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    BS
    BSX
    Boston Scientific Corp
    $48,54
    72,6B USD
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    IS
    ISRG
    INTUITIVE SURGICAL, INC.
    $376,00
    133,2B USD
    P/E
    287,7x
    +258,7 vs self
    Div yield
    vs self
    ROE
    3,6 %
    -15,8 vs self
    EW
    EW
    Edwards Lifesciences Corp
    $88,82
    51,6B USD
    P/E
    44,3x
    +15,3 vs self
    Div yield
    vs self
    ROE
    10,4 %
    -8,9 vs self

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    6,06
    Predicted surprise
    -0,00
    Beat probability
    45 %
    Analysts
    23
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-07-02 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Segment revenue · next quarter
    No quarterly segment estimate
    Segment data is reported at full-fiscal-year granularity only — no quarterly segment split is forecast (a quarterly figure is never inferred from the annual). See the full-fiscal-year segment-revenue card below.
    Full fiscal year~1 year ahead
    Segment-revenue forecast · full fiscal year · native currency
    • Lab Services, Consumables & AutomationFY2026 — next full year (forecast) · projected off FY2025 close, as of 2025-10-31 · conf —3,0BFORECAST
    • Life Sciences & Diagnostics InstrumentsFY2026 — next full year (forecast) · projected off FY2025 close, as of 2025-10-31 · conf —2,8BFORECAST
    • Analytical Instruments & SoftwareFY2026 — next full year (forecast) · projected off FY2025 close, as of 2025-10-31 · conf —1,3BFORECAST
    • Life Sciences & Diagnostics InstrumentsFY2024 — reported · conf —2,8BREPORTED
    • Lab Services, Consumables & AutomationFY2025 — reported · conf —2,8BREPORTED
    • Lab Services, Consumables & AutomationFY2024 — reported · conf —2,7BREPORTED
    • Life Sciences & Diagnostics InstrumentsFY2025 — reported · conf —2,5BREPORTED
    • Analytical Instruments & SoftwareFY2024 — reported · conf —1,4BREPORTED
    • Analytical Instruments & SoftwareFY2025 — reported · conf —1,3BREPORTED
    Model estimate of reported / forward segment revenue in issuer-native currency. Confidence shown where the model calibrated it; "—" where not (never inferred).
    Corporate eventM&A horizon
    M&A probabilityconf 3 %
    Probability
    3 %
    Base rate
    3 %
    Band
    180-day horizon · target 2027-01-19 · 1,0× base rate
    No acquirer candidates identified by the signal model.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$144,00
    Mean$160,49
    Median$159,00
    High$185,00
    Spot$4,64
    +3358.8 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-2,3 %Above median
    Net Margin-19,2 %Below median
    ROE-2,5 %Above median
    Capex / Rev-0,1 %Above P75
    D/E3,23Bottom quartile
    Cash Conv-1,07Bottom quartile

    Corporate actions / M&A

    M&A probabilityconf —
    Probability
    3 %
    Base rate
    3 %
    Band
    Low
    180-day horizon · target 2027-01-19 · 1,0× base rate
    No acquirer candidates identified by the signal model.
    Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Areeya Property PCL Market data — financials · 2026-05-27

    Ownership & reference

    Leadership

    • Wisit LaohapoonrungseeChairman of the Board, Chief Executive Officer

    Insider activity

    Net selling0 buys · 1 sellsnet -$217K9 insiders · last 365d
    • KIRKWOOD JONAH PREVOSTSenior Vice President · Common StockOther 30 @ $136,01$4K · 2026-06-26
    • MCDONNELL PADRAIGDirector, President and CEO · Common StockOther 418 @ $137,40$57K · 2026-06-03
    • Dolsten MikaelDirector · Common StockSold 1 600 @ $135,42$217K · 2026-05-29
    • Buckner Michael StevenSenior Vice President · Common StockOther 8 872 · 2026-05-19
    • MAY SIMONSenior Vice President · Common StockOther 368 @ $115,62$43K · 2026-05-08
    • Henson MeghanSenior Vice President · Common StockOther 153 @ $113,98$17K · 2026-03-31
    • SCANGOS GEORGE ADirector · Common StockOther 2 158 @ $111,75$241K · 2026-03-19
    • SCANGOS GEORGE ADirector · Common StockOther 1 057 @ $111,75$118K · 2026-03-19
    • BRAWLEY OTIS WDirector · Common StockOther 2 158 @ $111,75$241K · 2026-03-19
    • Rataj Sue H.Director · Common StockOther 2 158 @ $111,75$241K · 2026-03-19
    • BRAWLEY OTIS WDirector · Common StockOther 888 @ $111,75$99K · 2026-03-19

    Short positioning

    7.5Mshares short+41.4% vs prior
    3.53days to cover
    64.9%short of daily vol
    6.6Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)
    Index membership
    S&P 500United States

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    A.BKCanonical
    SET (Bangkok) · USD

    Intel & risk

    PredictorBeat prob45 %Surprise-0,00M&A prob3 %Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    AEX21:05bEX21:283EX21:2d3EX21:3f5EX21:518EX21:62cEX21:ac2EX21:b63EX21:eddEX21:f73Advanced Medic
    This companySectorSubsidiaries

    Evidence & claims

    From filings & derived data
    • Debt-to-equity (FY 2026-01-31): 0.85xDerived (calculated)
    • Long-term debt (YoY) (2026-01-31 vs 2025-01-31): -8.9%Derived (calculated)
    • Shareholders' equity (YoY) (2026-01-31 vs 2025-01-31): 14.6%Derived (calculated)
    • Cash & equivalents (YoY) (2026-01-31 vs 2025-01-31): 19.8%Derived (calculated)
    • Total assets (YoY) (2026-01-31 vs 2025-01-31): 7.5%Derived (calculated)
    • Total liabilities (YoY) (2026-01-31 vs 2025-01-31): 0.3%Derived (calculated)
    • Current ratio (FY 2026-01-31): 2.07xDerived (calculated)
    • Total assets (annual): USD 12.81BSEC XBRL filing
    • Long-term debt (annual): USD 3.05BSEC XBRL filing
    • Current liabilities (annual): USD 2.23BSEC XBRL filing
    • Total liabilities (annual): USD 5.91BSEC XBRL filing
    • Shares outstanding (annual): 282.7MSEC XBRL filing
    • Current assets (annual): USD 4.62BSEC XBRL filing
    • Shareholders' equity (annual): USD 6.91BSEC XBRL filing
    • Cash & equivalents (annual): USD 1.76BSEC XBRL filing
    • Net income (YoY) (2025-10-31 vs 2024-10-31): 1.1%Derived (calculated)
    • Capex (YoY) (2025-10-31 vs 2024-10-31): 7.7%Derived (calculated)
    • Cost of revenue (YoY) (2025-10-31 vs 2024-10-31): 11.1%Derived (calculated)
    • EPS (diluted) (YoY) (2025-10-31 vs 2024-10-31): 3.2%Derived (calculated)
    • R&D expense (YoY) (2025-10-31 vs 2024-10-31): -5.0%Derived (calculated)
    • Revenue (YoY) (2025-10-31 vs 2024-10-31): 6.7%Derived (calculated)
    • Operating income (YoY) (2025-10-31 vs 2024-10-31): -0.6%Derived (calculated)
    • EPS (basic) (YoY) (2025-10-31 vs 2024-10-31): 3.4%Derived (calculated)
    • Operating cash flow (YoY) (2025-10-31 vs 2024-10-31): -11.0%Derived (calculated)
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-08-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-08-04 05:43 UTCSAGAAI Chip Selloff ECB Pivot Semiconductor stocks plunge amid AI bubble fears while the European Central Bank signals readiness for further rate hikes, challenging dovish market consensus.
    2026-08-03 17:58 UTCSAGATech Selloff Spreads Globally Nasdaq futures slide as AI spending concerns and South Korean tech weakness trigger a broad-based equity rout across US and Asian markets.
    2026-08-03 14:07 UTCSAGATech and Retail Earnings Volatility Hims & Hers and Shake Shack shares plummet on earnings misses while Meta and Google intensify AI competition.
    2026-07-31 06:05 UTCSAGAAI Chip Market Volatility Samsung profits surge on memory demand while Micron shares plunge, triggering mixed reactions across Indian and South Korean technology indices.
    2026-07-02 04:10 UTCNEWSBYD and Xiaomi shares surge on strong June EV delivery data → Robust monthly sales figures from China's top electric vehicle makers helped lift sentiment across Asian equities, with BYD leading the rally.
    2026-07-01 20:18 UTCNEWSMicron plunges 11% as chip sector opens Q3 with sharp reversal → The memory maker's $138 billion wipeout signals profit-taking after a record second quarter, casting doubt on the sustainability of the AI-driven rally.
    2026-07-01 18:20 UTCNEWSMicron and SanDisk lead semiconductor selloff as AI trade faces stress test → Rotation out of high-flying tech names intensifies, with memory chip makers under pressure despite persistent supply constraints.
    2026-07-01 12:50 UTCNEWSMicron and GM sign vehicle memory supply deal as sector rallies → The agreement locks in a key automotive customer for Micron, reinforcing the memory chipmaker's diversification beyond data centers amid a broader semiconductor rally.
    2026-07-01 00:44 UTCNEWSKospi opens higher as chip rally extends on Micron earnings tailwind → South Korean equities gained ground at the open, with technology shares leading the advance following a stronger-than-expected earnings report from US memory chipmaker Micron.
    2026-07-01 00:12 UTCNEWSSeoul stocks open higher as chip rally extends into Wednesday session → Korean equities gain ground on continued semiconductor strength, with investors also monitoring the National Pension Service's upcoming rebalancing moves.
    2026-07-01 00:09 UTCNEWSKospi opens 1.36% higher as chip rally extends → South Korean equities continue their upward trajectory, defying broader global tech weakness. The rally is anchored by strong sentiment in the semiconductor sector following Micron's earnings beat.
    2026-06-30 20:47 UTCNEWSMicron, Intel and AMD add $2 trillion in combined value as AI rally broadens beyond Nvidia → Investors widened their semiconductor exposure in the second quarter, driving a record valuation surge for chipmakers outside the Nvidia ecosystem.
    2026-06-30 18:50 UTCNEWSNvidia lags peers as chip sector posts record quarter → The AI chip leader underperformed a broader semiconductor rally driven by memory and foundry strength, raising questions about valuation limits.
    2026-06-30 17:11 UTCNEWSAI investment cycle shifts focus to memory chips as demand surges → Wall Street is reassessing the semiconductor landscape as the AI infrastructure build-out moves beyond GPUs into high-bandwidth memory, following Micron's recent results.
    2026-06-30 15:11 UTCNEWSSemiconductor rally stalls as AI valuation concerns weigh on chip stocks → AI-fuelled chip stock rally hits speed bump despite record quarterly gains.
    2026-06-30 13:56 UTCNEWSUS equities on track for strongest quarterly rally in six years → Futures point to a positive open as broad-based gains in tech and energy sectors push major indices toward record-breaking second-quarter returns.
    2026-06-30 12:07 UTCNEWSBernstein upgrades Micron outlook as memory chip maker posts eightfold 2026 rally → The investment bank maintains an outperform rating on the stock, citing continued momentum following the company's recent earnings beat and strong guidance.
    2026-06-30 04:45 UTCNEWSAsian equities on track for strongest quarter in nearly two decades → Regional markets close out a record-breaking second half, buoyed by robust earnings from US semiconductor giants Micron and Qualcomm that helped dispel investor anxiety.
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: ma_probability (180d)
    2026-06-28 21:51 UTCNEWSMicron market cap tops $1.3 trillion as AI memory shortage fuels rally → Shares surged 18.4% to $1,236, briefly surpassing Meta and Tesla in valuation as investors price in persistent supply constraints for AI data centers.
    2026-06-28 18:00 UTCNEWSSemiconductor rally broadens as analysts highlight CPU demand surge → UBS points to hyperscale cloud providers driving a shift toward CPU-intensive workloads, lifting shares of AMD and ARM alongside Micron's recent momentum.
    2026-06-28 14:03 UTCNEWSMicron poised to join Nvidia and Google at the top of U.S. corporate profitability → Memory chip maker's surging margins reflect the structural shift in data-center economics, reinforcing the sector's rally.
    2026-06-28 03:45 UTCEARNINGSUpcomingForecast: fundamentals_forecast (365d)
    2026-06-27 16:44 UTCNEWSOil prices retreat as Wall Street rotates out of AI tech → Brent crude fell sharply this week, providing a tailwind for inflation expectations even as skepticism over AI valuations weighed on equities.
    2026-06-26 13:30 UTCNEWSChinese chipmakers surge on debut as $1bn IPOs signal capital market resilience → Strong opening gains for two semiconductor listings in Hong Kong underscore investor appetite for the sector, following a broader rally across Asian tech equities.
    2026-06-26 12:33 UTCNEWSUS equity futures slide as global tech sell-off resumes → Nasdaq futures drop 1.1% and S&P 500 futures fall up to 1%, extending a multi-day retreat in technology stocks despite Micron's strong earnings.
    2026-06-26 12:08 UTCNEWSMicron shares trade near $1,028 as analysts flag valuation reset ahead of Q3 earnings → Wall Street sees a potential inflection point for the memory chip maker, arguing current multiples are disconnected from the AI-driven demand cycle.
    2026-06-26 08:03 UTCNEWSMicron results signal shift in how Wall Street prices AI memory demand → Explosive quarterly performance suggests a structural repricing of the memory sector, with implications for broader AI infrastructure valuations.
    2026-06-26 00:00 UTCINSIDER2 insider transactions — 2026-06
    2026-06-26 00:00 UTCINSIDER2 insider transactions — 2026-06
    2026-06-26INSIDERKIRKWOOD JONAH PREVOST transacted 30 sh — Senior Vice President ~$4k
    2026-06-25 22:14 UTCNEWSBHP-backed I-Pulse secures $250 million US CHIPS Act award for silicon-carbide expansion → The funding underscores Washington's push to diversify power electronics supply chains, adding to a day of strong semiconductor sector momentum.
    2026-06-25 21:31 UTCNEWSNasdaq extends slide as Apple sells off; oil rises on Hormuz risk → Tech weakness drags the Nasdaq to a fourth straight loss while energy prices gain ground amid persistent shipping concerns in the Strait of Hormuz.
    Showing the 40 most recent of 119 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage